At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Aramchol (drug)
- How long the study runs
- Study runs about 10 months (dates as stated)
- About the drug or intervention
- Aramchol — drug: Aramchol tablet at 2 different single doses
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 18 Years to 55 Years
- Who
- All
- Number of participants
- 32
- Started
- 2025-12-25
- Last checked
- 2026-09
Plain English Summary
What is this study?
- • Testing a new treatment for healthy
- • Phase1 - 32 participants
- • Evaluate the exposure of of Aramchol from 2 different single doses of Aramchol meglumine tablet and to compare the exposure of steady state from a selected dose of Aramchol meglumine tablet
Who can take part?
- • Ages 18 Years to 55 Years
- • Diagnosed with healthy
Where?
- • London - Hammersmith Medicines Research (HMR)
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Evaluate the exposure of of Aramchol from 2 different single doses of Aramchol meglumine tablet and to compare the exposure of steady state from a selected dose of Aramchol meglumine tablet.
More detail
Evaluate the exposure of of Aramchol from 2 different single doses of Aramchol meglumine tablet and to compare the exposure of steady state from a selected dose of Aramchol meglumine given one daily with that from a 300 mg dose of Aramchol free acid tablets given twice daily in adult Healthy volunteers.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years - 55 Years
- Who can join: All genders
What the study is looking for
- ✓Male or female healthy volunteers with body mass index (BMI) in the range of 18-30.9 kg/ m2 inclusive
- ✓Deemed healthy on the basis of clinical history, physical examination, ECG, vital signs, and laboratory tests of...
- ✓Agree to follow-up the contraception requirements of the trial
- ✓Able to give fully informed written consent
Who cannot take part
- ✗Females of reproductive potential who are pregnant or lactating
- ✗Positive tests for hepatitis B, C or HIV
- ✗History of sever adverse reaction to any drug
- ✗Known sensitivity to drug medication
- ✗Drug or alcohol abuse
See the full criteria
Where Is This Study? (1 UK site)
Hammersmith Medicines Research (HMR)
London NW10 7EW, United Kingdom
How to Get in Touch
Yossi Gilgun-Sherki, PhD, MBA
Sponsor contactCONTACT